Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]Fluoro-l-dopa positron emission tomography study with voxel-based analysis

Psychiatry Research - Neuroimaging

Volumn 154, Issue 2, 2007, Pages 115-124

  Bragulat, Véronique ^a,b,c,d   Paillère Martinot, Marie Laure ^a,b,c,d,e   Artiges, Eric ^a,b,c,d   Frouin, Vincent ^b   Poline, Jean Baptiste ^a,b,c,d   Martinot, Jean Luc ^a,b,c,d  

^a INSERM   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Cochin Hospital ^*  (France)

Author keywords

Depression; Dopa; Positron emission tomography

Indexed keywords

FLUORINE 18; LEVODOPA;

ADULT; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; DEPRESSION; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HYPOTHALAMUS; IMPULSIVENESS; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; PUTAMEN; SUBICULUM;

ADULT; AFFECT; BIOGENIC MONOAMINES; BRAIN STEM; CAUDATE NUCLEUS; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOXETINE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; HYPOTHALAMUS; IMPULSE CONTROL DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; NUCLEUS ACCUMBENS; POSITRON-EMISSION TOMOGRAPHY; PSYCHOMOTOR DISORDERS; PUTAMEN; RADIOPHARMACEUTICALS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 33847207536     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2006.07.002     Document Type: Article

References (41)

1. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes T.R., Lindgren K.A., Holden J.E., Perlman S.B., Turski P.A., Krahn D.D., Benca R.M., and Davidson R.J. Metabolic rate in the right amygdala predicts negative affect in depressed patients. NeuroReport 9 (1998) 3301-3307
2. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 9 (1986) 357-381
3. Arai R., Karasawa N., Geffard M., Nagatsu T., and Nagatsu I. Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous l-DOPA in rat, with reference to the involvement of aromatic l-amino acid decarboxylase. Brain Research 667 (1994) 295-299
4. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. American Journal of Psychiatry 157 (2000) 115-117
5. Brett M., Anton J.L., Valbregue R., and Poline J.B. Region of interest analysis using an SPM toolbox. NeuroImage Human Brain Mapping, Meeting. Poster vol. 10511 (2002). http://www.academicpress.com/journals/hbm2002/15444.html www.academicpress.com/journals/hbm2002/15444.html
6. Brown W.D., Taylor M.D., Roberts A.D., Oakes T.R., Schueller M.J., Holden J.E., Malischke L.M., DeJesus O.T., and Nickles R.J. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology 53 (1999) 1212-1218
7. Chau D.T., Roth R.M., and Green A.I. The neural circuitry of reward and its relevance to psychiatric disorders. Current Psychiatry Reports 6 (2004) 391-399
8. Cordes M., Snow B.J., Cooper S., Schulzer M., Pate B.D., Ruth T.J., and Calne D.B. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Annals of Neurology 36 (1994) 667-670
9. Cummings J.L. Frontal subcortical circuits and human behavior. Archives of Neurology 50 (1993) 873-880
10. 18F]-Fluoro-l-DOPA by radiofluorodestannylation: a short and simple synthesis of a new labelling precursor. Journal of Labelled Compounds & Radiopharmaceuticals 41 (1998) 105-114
11. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorder. Current Opinion in Neurobiology 11 (2001) 240-249
12. Drevets W.C., Gadde K.M., and Krishnan R.R. Neuroimaging studies of mood disorders. In: Charney D.S., Nestler E.J., and Bunney B.S. (Eds). Neurobiology of Mental Illness (1999), Oxford University Press, New York 394-418
13. DSM-IV, American Psychiatric Association. Manuel diagnostique et statistique des Troubles mentaux, 4ème édition (Version Internationale, Washington, DC, 1995). Traduction française par Guelfi, J.D., Crocq, M.A., Masson, Paris, 1996.
14. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N.A., Friston K.J., and Frackowiak R.S.J. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14 (2001) 21-36
15. Herman J.P., and Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences 20 (1997) 78-84
16. Hirayasu Y., Shenton M.E., Salisburry D.F., Kwon J.S., Wible C.G., Fischer I.A., Yurgelun-Todd D., Zarate C., Kikinis R., Jolesz F.A., and McCarley R.W. Subgenual cingulate cortex volume in first-episode psychosis. American Journal of Psychiatry 156 (1999) 1091-1093
17. 18F]fluoro-l-dopa PET study. Brain 125 (2002) 1358-1365
18. Jouvent R., Vindreau C., Montreuil M., Bungener C., and Widlöcher D. Polydimensional rating scale of depression mood. Psychiatry & Psychobiology 3 (1988) 245-253
19. 18F]fluorodopamine storage capacity. Journal of Cerebral Blood Flow and Metabolism 25 7 (2005) 807-819
20. Kunzel H.E., Binder E.B., Nickel T., Ising M., Fuchs B., Majer M., Pfennig A., Ernst G., Kern N., Schmid D.A., Uhr M., Holsboer F., and Modell S. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28 (2003) 2169-2178
21. Maes F., Collignon A., Vandermeulen D., Marchal G., and Suetens P. Multimodality image registration by maximization of mutual information. IEEE Transactions on Medical Imaging 16 (1997) 187-198
22. Meyer-Lindenberg A., Miletich R., Kohn P.D., Esposito G., Carson R.E., Quarantelli M., Weinberger D.R., and Berman K.F. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nature Neuroscience 5 (2002) 267-271
23. Montgomery S.A., and Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134 (1979) 382-389
24. O'Donnell P., and Grace A.A. Synaptic interactions among excitatory afferents in nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. Journal of Neuroscience 15 (1995) 3622-3629
25. Paillère-Martinot M.L., Bragulat V., Artiges E., Dollé F., Hinnen F., Jouvent R., and Martinot J.L. Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. American Journal of Psychiatry 158 (2001) 314-316
26. Parent A. Extrinsic connections of the basal ganglia. Trends in Neurosciences 13 (1990) 254-258
27. Patlak C.S., and Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. Journal of Cerebral Blood Flow and Metabolism 5 (1985) 584-590
28. Pierson A., Ragot R., Van Hooff J., Partiot A., Renault B., and Jouvent R. Heterogeneity of information-processing alterations according to dimensions of depression: an event-related potentials study. Biological Psychiatry 40 (1996) 98-115
29. Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?. Movement Disorders Suppl. 7 (2003) S43-S51
30. Pycock C.J., Kerwin R.W., and Carter C.J. Effects of lesions of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286 (1980) 74-77
31. 18F]-fluorodopa uptake rate using three-dimensional PET. In: Carson R., Daube-Witherspoon M.E., and Herscovitch P. (Eds). Quantitative Functional Brain Imaging With Positron Emission Tomography (1998), Academic Press, San Diego 117-123
32. Remy P., Doder M., Lees A., Turjanski N., and Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128 Pt.6 (2005) 1314-1322
33. Ribeiro M.J., Vidailhet M., Loc'h C., Dupel C., Nguyen J.P., Ponchant M., Dolle F., Peschanski M., Hantraye P., Cesaro P., Samson Y., and Remy P. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Archives of Neurology 59 (2002) 580-586
34. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 Suppl. 20 (1998) 22-33
35. Sheline Y.I., Wang P.W., Gado M.H., and Csernansky J.G. Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 3908-3913
36. 2A receptors in midlife than in late life. American Journal of Psychiatry 159 (2002) 430-435
37. Sobin C., and Sackeim H.A. Psychomotor symptoms of depression. American Journal of Psychiatry 154 (1997) 4-17
38. Swerdlow N.R., and Koob G.F. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Research 412 (1987) 233-243
39. Van Veen V., Cohen J.D., Botvinick M.M., Stenger V.A., and Carter C.S. Anterior cingulate cortex, conflict monitoring, and levels of processing. NeuroImage 14 6 (2001) 1302-1308
40. Watanabe K., and Kimura M. Dopamine receptor-mediated mechanisms involved in the expression of learned activity of primate striatal neurons. Journal of Neurophysiology 79 (1998) 2568-2580
41. Widlöcher D.J. Psychomotor retardation: clinical, theoretical and psychometric aspects. Psychiatric Clinics of North America 6 (1983) 7-43